About AGN
Argenica Therapeutics Limited (AGN) is a Company engaged in research and development of a neuroprotective therapeutic drug. Its neuroprotective peptide candidate, ARG-007, has been demonstrated to improve outcomes in pre-clinical stroke models, traumatic brain injury (TBI) and hypoxic ischaemic encephalopathy (HIE).
Find out what a historical investment in Argenica Therapeutics would be worth today using our AGN stock calculator.
Market Capitalisation
$17M
Price-earnings ratio
-12.73
Dividend yield
-
High today
$0.13
Low today
$0.13
Open price
$0.13
52-week high
$0.35
52-week low
$0.09
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in AGN
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in AGN on Stake
- Buy AGN from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
AGN related stocks